A Role of SCN9A in Human Epilepsies, As a Cause of Febrile Seizures and As a Potential Modifier of Dravet Syndrome

A follow-up study of a large Utah family with significant linkage to chromosome 2q24 led us to identify a new febrile seizure (FS) gene, SCN9A encoding Nav1.7. In 21 affected members, we uncovered a potential mutation in a highly conserved amino acid, p.N641Y, in the large cytoplasmic loop between transmembrane domains I and II that was absent from 586 ethnically matched population control chromosomes. To establish a functional role for this mutation in seizure susceptibility, we introduced the orthologous mutation into the murine Scn9a ortholog using targeted homologous recombination. Compared to wild-type mice, homozygous Scn9a N641Y/N641Y knockin mice exhibit significantly reduced thresholds to electrically induced clonic and tonic-clonic seizures, and increased corneal kindling acquisition rates. Together, these data strongly support the SCN9A p.N641Y mutation as disease-causing in this family. To confirm the role of SCN9A in FS, we analyzed a collection of 92 unrelated FS patients and identified additional highly conserved Nav1.7 missense variants in 5% of the patients. After one of these children with FS later developed Dravet syndrome (severe myoclonic epilepsy of infancy), we sequenced the SCN1A gene, a gene known to be associated with Dravet syndrome, and identified a heterozygous frameshift mutation. Subsequent analysis of 109 Dravet syndrome patients yielded nine Nav1.7 missense variants (8% of the patients), all in highly conserved amino acids. Six of these Dravet syndrome patients with SCN9A missense variants also harbored either missense or splice site SCN1A mutations and three had no SCN1A mutations. This study provides evidence for a role of SCN9A in human epilepsies, both as a cause of FS and as a partner with SCN1A mutations.

[1]  E. Scholl,et al.  Developing novel antiepileptic drugs: Characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models , 2009, Neurotherapeutics.

[2]  K. Wilcox,et al.  Discovery of antiepileptic drugs , 2011, Neurotherapeutics.

[3]  K. Wilcox,et al.  Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions , 2009, Epilepsia.

[4]  I. Scheffer,et al.  Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? , 2009, Brain and Development.

[5]  Petter Laake,et al.  Recommended tests for association in 2×2 tables , 2009, Statistics in medicine.

[6]  J. Gargus.  Genetic Calcium Signaling Abnormalities in the Central Nervous System: Seizures, Migraine, and Autism , 2009, Annals of the New York Academy of Sciences.

[7]  C. Depienne,et al.  Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients , 2008, Journal of Medical Genetics.

[8]  M. Leppert,et al.  Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization , 2008, The Journal of physiology.

[9]  M. Meisler,et al.  Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy , 2008, Neuroscience Letters.

[10]  Fbj Young.  When adaptive processes go awry: gain‐of‐function in SCN9A , 2007, Clinical genetics.

[11]  Bert Sakmann,et al.  Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy , 2007, Proceedings of the National Academy of Sciences.

[12]  Haitao Cheng,et al.  Consensus Data Mining (CDM) Protein Secondary Structure Prediction Server: Combining GOR V and Fragment Database Mining (FDM) , 2007, Bioinform..

[13]  C. Fertleman,et al.  Paroxysmal extreme pain disorder (previously familial rectal pain syndrome) , 2007, Neurology.

[14]  Melinda S. Martin,et al.  Characterization of 5' untranslated regions of the voltage-gated sodium channels SCN1A, SCN2A, and SCN3A and identification of cis-conserved noncoding sequences. , 2007, Genomics.

[15]  I. Scheffer,et al.  SCN2A Mutations and Benign Familial Neonatal‐Infantile Seizures: The Phenotypic Spectrum , 2007, Epilepsia.

[16]  Hiroyuki Miyamoto,et al.  Nav1.1 Localizes to Axons of Parvalbumin-Positive Inhibitory Interneurons: A Circuit Basis for Epileptic Seizures in Mice Carrying an Scn1a Gene Mutation , 2007, The Journal of Neuroscience.

[17]  M. Dubé,et al.  Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations , 2007, Clinical genetics.

[18]  D. Adams,et al.  Atypical patterns of inheritance. , 2007, Seminars in pediatric neurology.

[19]  I. Scheffer,et al.  The spectrum of SCN1A-related infantile epileptic encephalopathies. , 2007, Brain : a journal of neurology.

[20]  J. Aicardi,et al.  Aicardi's Epilepsy in Children. , 2012, Journal of child neurology.

[21]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[22]  Istvan Mody,et al.  Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy , 2006, Proceedings of the National Academy of Sciences.

[23]  John N. Wood,et al.  SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes , 2006, Neuron.

[24]  L. Lagae,et al.  Microdeletions involving the SCN1A gene may be common in SCN1A‐mutation‐negative SMEI patients , 2006, Human mutation.

[25]  A. M. Rush,et al.  A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Chabbert,et al.  Molecular diversity of voltage-gated sodium channel alpha subunits expressed in neuronal and non-neuronal excitable cells , 2005, Neuroscience.

[27]  T. Strom,et al.  Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine , 2005, The Lancet.

[28]  Steven Petrou,et al.  SCN1A mutations and epilepsy , 2005, Human mutation.

[29]  W. Bell.  Aicardi’s Epilepsy in Children, 3rd ed , 2005 .

[30]  K. Yamakawa,et al.  Seizure phenotypes of a family with missense mutations in SCN2A. , 2004, Pediatric neurology.

[31]  H. Oguni,et al.  Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity , 2004, Neurology.

[32]  B. Ding,et al.  Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia , 2004, Journal of Medical Genetics.

[33]  R M Gardiner,et al.  Sodium channel α1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms , 2003, Neurology.

[34]  I. Scheffer,et al.  The genetics of human epilepsy. , 2003, Trends in pharmacological sciences.

[35]  E. Bertini,et al.  Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy , 2003, Neurology.

[36]  Berten Ceulemans,et al.  De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy , 2003, Human mutation.

[37]  W. Frankel,et al.  Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold. , 2003, Human molecular genetics.

[38]  Federico Zara,et al.  Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. , 2003, Epileptic disorders : international epilepsy journal with videotape.

[39]  Yukitoshi Takahashi,et al.  Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. , 2003, Brain : a journal of neurology.

[40]  L. Lagae,et al.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. , 2001, American journal of human genetics.

[41]  W. Frankel,et al.  Mouse models for the Wolf-Hirschhorn deletion syndrome. , 2001, Human molecular genetics.

[42]  Stéphanie Baulac,et al.  Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2 , 2000, Nature Genetics.

[43]  W. Catterall,et al.  From Ionic Currents to Molecular Mechanisms The Structure and Function of Voltage-Gated Sodium Channels , 2000, Neuron.

[44]  G. Ebers,et al.  Evidence Favoring Genetic Heterogeneity for Febrile Convulsions , 2000, Epilepsia.

[45]  A. Peiffer,et al.  A locus for febrile seizures (FEB3) maps to chromosome 2q23‐24 , 1999, Annals of neurology.

[46]  J. Greer,et al.  Targeting genes for self-excision in the germ line. , 1999, Genes & development.

[47]  I. Scheffer,et al.  Generalized epilepsy with febrile seizures plus: A common childhood‐onset genetic epilepsy syndrome , 1999, Annals of neurology.

[48]  W. Johnson,et al.  Genetics of the febrile seizure susceptibility trait , 1998, Brain and Development.

[49]  H. Klitgaard,et al.  Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man , 1998, Epilepsy Research.

[50]  K. Wong,et al.  A Novel Tetrodotoxin-sensitive, Voltage-gated Sodium Channel Expressed in Rat and Human Dorsal Root Ganglia* , 1997, The Journal of Biological Chemistry.

[51]  S. Berkovic,et al.  Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. , 1996, Journal of medical genetics.

[52]  D. Mandelbaum,et al.  Pedigree analysis in families with febrile seizures. , 1996, American journal of medical genetics.

[53]  J. Roder,et al.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Racine.  Modification of seizure activity by electrical stimulation: cortical areas. , 1975, Electroencephalography and clinical neurophysiology.

[55]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.